drugset / Trial / NCT03585829

Ramadan Fasting in Patients With Corticotrope Deficiency Treated Either by Hydrocortisone or by Prednisolone

NCT03585829

Phase 4 Completed 53 enrolled University Tunis El Manar
RandomizedCrossoverDouble-blindTreatment

Summary

Selected patients will be randomised to either hydrocortisone or prednisolone. Each treatment period is of 14 days. Abnormal clinical symptoms, blood glucose and quality of life will be monitored.

Timeline

Start
2018-05-17
Primary completion
2018-06-16
Completion
2018-07-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified 20 mg
Comparator Prednisolone Other / unclassified 5 mg

Indications